Eoin OʼBrien

39.0k total citations · 12 hit papers
268 papers, 21.5k citations indexed

About

Eoin OʼBrien is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eoin OʼBrien has authored 268 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Cardiology and Cardiovascular Medicine, 80 papers in Surgery and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eoin OʼBrien's work include Blood Pressure and Hypertension Studies (195 papers), Heart Rate Variability and Autonomic Control (77 papers) and Cardiovascular Health and Disease Prevention (57 papers). Eoin OʼBrien is often cited by papers focused on Blood Pressure and Hypertension Studies (195 papers), Heart Rate Variability and Autonomic Control (77 papers) and Cardiovascular Health and Disease Prevention (57 papers). Eoin OʼBrien collaborates with scholars based in Ireland, Belgium and United Kingdom. Eoin OʼBrien's co-authors include Jan A. Staessen, Peter Sever, Neil R Poulter, Neil Atkins, Eamon Dolan, Mark J. Caulfield, Gordon T. McInnes, Hans Wedel, Jesper Mehlsen and Sverre E. Kjeldsen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Eoin OʼBrien

262 papers receiving 20.4k citations

Hit Papers

Prevention of coronary and stroke events with atorvastati... 2001 2026 2009 2017 2003 2005 2003 2010 2005 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
    2003 2.7k citations Eoin OʼBrien et al. profile →
  2. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
    2005 1.9k citations Eoin OʼBrien et al. profile →
  3. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement
    2003 1.3k citations Eoin OʼBrien, Yutaka Imai et al. Journal of Hypertension profile →
  4. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
    2010 1.3k citations Eamon Dolan, Eoin OʼBrien et al. profile →
  5. Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality
    2005 926 citations Eamon Dolan, Alice Stanton et al. Hypertension profile →
  6. Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension
    2003 803 citations Robert Fagard, Eoin OʼBrien et al. profile →
  7. Blood pressure measuring devices: recommendations of the European Society of Hypertension
    2001 708 citations Eoin OʼBrien et al. BMJ profile →
  8. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study
    2007 660 citations José Boggia, Lutgarde Thijs et al. profile →
  9. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults
    2002 553 citations Eoin OʼBrien, Roland Asmar et al. Blood Pressure Monitoring profile →
  10. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke
    2010 480 citations Eamon Dolan, Eoin OʼBrien et al. profile →
  11. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement
    2021 427 citations George S. Stergiou, Paolo Palatini et al. Journal of Hypertension profile →
  12. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults
    2010 425 citations Eoin OʼBrien, Neil Atkins et al. Blood Pressure Monitoring profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eoin OʼBrien Ireland 58 15.9k 7.1k 4.1k 2.0k 1.6k 268 21.5k
Franz H. Messerli United States 80 16.2k 1.0× 3.2k 0.4× 5.5k 1.3× 2.4k 1.2× 766 0.5× 415 22.9k
Guy De Backer Belgium 64 12.3k 0.8× 7.5k 1.1× 5.6k 1.4× 1.4k 0.7× 2.7k 1.7× 304 24.3k
Michael A. Weber United States 69 16.8k 1.1× 3.6k 0.5× 6.5k 1.6× 3.2k 1.6× 719 0.5× 499 21.9k
Peter Sever United Kingdom 51 9.8k 0.6× 7.0k 1.0× 5.1k 1.2× 1.4k 0.7× 2.5k 1.6× 193 16.8k
Mark J. Caulfield United Kingdom 50 8.2k 0.5× 6.0k 0.8× 6.2k 1.5× 1.5k 0.7× 1.8k 1.2× 170 17.2k
Stevo Julius United States 74 22.0k 1.4× 3.8k 0.5× 8.3k 2.0× 2.7k 1.3× 873 0.5× 328 28.2k
Björn Dahlöf Sweden 48 13.4k 0.8× 2.8k 0.4× 6.0k 1.5× 1.9k 0.9× 1.1k 0.7× 172 16.7k
Daniel W. Jones United States 39 16.0k 1.0× 5.0k 0.7× 4.7k 1.2× 2.5k 1.2× 1.3k 0.8× 115 26.3k
Wilbert S. Aronow United States 66 13.7k 0.9× 5.2k 0.7× 2.2k 0.5× 916 0.5× 900 0.6× 1.2k 22.2k
Jan Östergren Sweden 48 14.2k 0.9× 4.7k 0.7× 5.6k 1.4× 720 0.4× 1.7k 1.0× 140 19.7k

Countries citing papers authored by Eoin OʼBrien

Since Specialization
Citations

This map shows the geographic impact of Eoin OʼBrien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eoin OʼBrien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eoin OʼBrien more than expected).

Fields of papers citing papers by Eoin OʼBrien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eoin OʼBrien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eoin OʼBrien. The network helps show where Eoin OʼBrien may publish in the future.

Co-authorship network of co-authors of Eoin OʼBrien

This figure shows the co-authorship network connecting the top 25 collaborators of Eoin OʼBrien. A scholar is included among the top collaborators of Eoin OʼBrien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eoin OʼBrien. Eoin OʼBrien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azzari, Chiara, et al.. (2020). The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies. SHILAP Revista de lepidopterología. 2 indexed citations
2.
Bilo, Grzegorz, Eamon Dolan, Eoin OʼBrien, et al.. (2019). The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study. European Journal of Preventive Cardiology. 27(4). 355–364. 38 indexed citations
3.
Yang, Wen‐Yi, Lutgarde Thijs, Zhen‐Yu Zhang, et al.. (2018). Evidence-based proposal for the number of ambulatory readings required for assessing blood pressure level in research settings: an analysis of the IDACO database. Blood Pressure. 27(6). 341–350. 23 indexed citations
4.
OʼBrien, Eoin, et al.. (2017). Motivating the Use of Different Macro-prudential Instruments: the Countercyclical Capital Buffer vs. Borrower-Based Measures. Economics Letters. 1 indexed citations
5.
OʼBrien, Eoin, Neil Atkins, George S. Stergiou, et al.. (2010). European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Pressure Monitoring. 15(1). 23–38. 425 indexed citations breakdown →
6.
Stettler, Christoph, Nicholas Witt, Robyn J. Tapp, et al.. (2009). Serum Amyloid A, C-Reactive Protein, and Retinal Microvascular Changes in Hypertensive Diabetic and Nondiabetic Individuals. Diabetes Care. 32(6). 1098–1100. 17 indexed citations
7.
Staessen, Jan A., Lutgarde Thijs, Robert Fagard, et al.. (2004). Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. Journal of Hypertension. 22(4). 847–857. 147 indexed citations
8.
OʼBrien, Eoin. (2003). Ambulatory blood pressure measurement is indispensable to good clinical practice. Journal of Hypertension. 21(2). S11–S18. 21 indexed citations
9.
OʼBrien, Eoin. (2002). Has conventional sphygmomanometry ended with the banning of mercury?. Blood Pressure Monitoring. 7(1). 37–40. 30 indexed citations
10.
OʼBrien, Eoin, et al.. (2001). Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 322(7285). 531.1–536. 708 indexed citations breakdown →
11.
OʼBrien, Eoin. (2000). Consequences of banning mercury and the cuff controversy. Blood Pressure Monitoring. 5(3). 33–34. 10 indexed citations
12.
13.
OʼBrien, Eoin. (1999). Modification of blood-pressure-measuring devices and the protocol of the British Hypertension Society. Blood Pressure Monitoring. 4(1). 53–54. 6 indexed citations
14.
OʼBrien, Eoin. (1997). Walk in peace: banish landmines from our globe. BMJ. 315(7120). 1456–1458. 3 indexed citations
15.
Staessen, Jan A., Lutgarde Thijs, Leszek Bieniaszewski, et al.. (1996). Ambulatory Monitoring Uncorrected for Placebo Overestimates Long-term Antihypertensive Action. Hypertension. 27(3). 414–420. 23 indexed citations
16.
Staessen, Jan A., CJ Bulpitt, Paul De Cort, et al.. (1993). (on behalf of the Syst-Eur Investigators). Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial. Journal of Human Hypertension. 7. 411–412. 4 indexed citations
17.
OʼBrien, Eoin & K O'Malley. (1990). Evaluation of blood pressure measuring devices with special reference to ambulatory systems.. PubMed. 8(7). S133–9. 14 indexed citations
18.
OʼBrien, Eoin, Desmond J. Fitzgerald, & K O'Malley. (1985). Blood pressure measurement: current practice and future trends.. BMJ. 290(6470). 729–734. 35 indexed citations
19.
OʼBrien, Eoin & K O'Malley. (1979). The sphygmomanometer.. BMJ. 2(6194). 851–853. 10 indexed citations
20.
OʼBrien, Eoin, et al.. (1971). Hepatorenal damage from toluene in a "glue sniffer".. BMJ. 2(5752). 29–30. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franz H. Messerli Breakdown of academic impact, for papers by Guy De Backer Breakdown of academic impact, for papers by Michael A. Weber Breakdown of academic impact, for papers by Peter Sever Breakdown of academic impact, for papers by Mark J. Caulfield Breakdown of academic impact, for papers by Stevo Julius Breakdown of academic impact, for papers by Björn Dahlöf Breakdown of academic impact, for papers by Daniel W. Jones Breakdown of academic impact, for papers by Wilbert S. Aronow Breakdown of academic impact, for papers by Jan Östergren
Rankless by CCL
2026